Home > Back to Publisher > Report Information

Pulmonary/Lung Disease Therapeutics: Worldwide Markets and Developments

PJB Publications USA Inc.
August 1, 2002
364 Pages - SKU: VB803325

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

Pulmonary/Lung Disease Therapeutics: Worldwide Markets and Developments

Pulmonary disease covers a wide range of disorders, from relatively benign conditions such as cough, cold, and allergy to potentially life-threatening conditions such as asthma and chronic obstructive pulmonary disease (COPD). In the U.S., lung disease is ranked as the fourth-leading cause of death (after heart disease, cancer, and stroke) and is responsible for approximately 1 in 7 deaths. However, while the death rates for heart disease and cancer are in decline, the death rate for lung disease is increasing.

This report provides analyses of the U.S. and world markets for drug therapeutics to treat pulmonary/lung diseases and disorders. The total worldwide market for therapeutics to treat the following specified pulmonary diseases is estimated to reach $17 billion in 2002:

COPD
Asthma
Cystic fibrosis
Pulmonary fibrosis
Pulmonary hypertension
Pulmonary embolism
Pulmonary sarcoidosis
Bronchopulmonary dysplasia
Respiratory distress syndrome

The report focuses on pulmonary disease therapies worldwide and includes an analysis of future developments in the treatment of respective conditions. Global regional market size projections (in U.S. dollars) and shares are covered, as well as discussion of market competitors and products.

Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

1 Executive Summary

2 Introduction

3 Chronic Obstructive Pulmonary Disease

4 Asthma

5 Cystic Fibrosis

6 Pulmonary Fibrosis

7 Pulmonary Hypertension

8 Pulmonary Embolism

9 Pulmonary Sarcoidosis

10 Bronchopulmonary Dysplasia

11 Respiratory Distress Syndrome

12 Company Profiles

13 Company Directory

14 References

List of Tables

Table 1-1 Total World Market Size Projection of Pulmonary/Lung Disease Therapeutics 2002, 2007
Table 1-2 World Pulmonary/Lung Disease Therapeutic Market Shares by Disease Type 2002, 2007
Table 2-1 Deaths From Pulmonary Disease in the U.S. (Excluding Cancer) Percent by Subgroup 1999
Table 3-1 Total World COPD Drug Market Size Projection 2002, 2007
Table 3-2 COPD Drug Market Size Projection by Geographic Region 2002, 2007
Table 3-3 Geographic Market Shares of COPD Drugs 2002
Table 3-4 Geographic Market Shares of COPD Drugs 2007
Table 4-1 Total World Asthma Drug Market Size Projection 2002, 2007
Table 4-2 Asthma Drug Market Size Projection by Geographic Region 2002, 2007
Table 4-3 Geographic Market Shares of Asthma Drugs 2002
Table 4-4 Geographic Market Shares of Asthma Drugs 2007
Table 4-5 World Asthma Drug Market Share by Drug Class 2002
Table 5-1 Total World Cystic Fibrosis Drug Market Size Projection 2002, 2007
Table 5-2 Cystic Fibrosis Drug Market Size Projection by Geographic Region 2002, 2007
Table 5-3 Geographic Market Shares of Cystic Fibrosis Drugs 2002
Table 5-4 Geographic Market Shares of Cystic Fibrosis Drugs 2007
Table 5-5 Cystic Fibrosis Foundation Research Grants, 5 Largest by Company
Table 6-1 Total World Pulmonary Fibrosis Drug Market Size Projection 2002, 2007
Table 6-2 Pulmonary Fibrosis Drug Market Size Projection by Geographic Region 2002, 2007
Table 6-3 Geographic Market Shares of Pulmonary Fibrosis Drugs 2002
Table 6-4 Geographic Market Shares of Pulmonary Fibrosis Drugs 2007
Table 7-1 Total World Pulmonary Hypertension Drug Market Size Projection 2002, 2007
Table 7-2 Pulmonary Hypertension Drug Market Size Projection by Geographic Region 2002, 2007
Table 7-3 Geographic Market Shares of Pulmonary Hypertension Drugs 2002
Table 7-4 Geographic Market Shares of Pulmonary Hypertension Drugs 2007
Table 8-1 Total World Pulmonary Embolism Drug Market Size Projection 2002, 2007
Table 8-2 Pulmonary Embolism Drug Market Size Projection by Geographic Region 2002, 2007
Table 8-3 Geographic Market Shares of Pulmonary Embolism Drugs 2002
Table 8-4 Geographic Market Shares of Pulmonary Embolism Drugs 2007
Table 9-1 Total World Pulmonary Sarcoidosis Drug Market Size Projection 2002, 2007
Table 9-2 Pulmonary Sarcoidosis Drug Market Size Projection by Geographic Region 2002, 2007
Table 9-3 Geographic Market Shares of Pulmonary Sarcoidosis Drugs 2002
Table 9-4 Geographic Market Shares of Pulmonary Sarcoidosis Drugs 2007
Table 10-1 Total World Bronchopulmonary Dysplasia Drug Market Size Projection 2002, 2007
Table 10-2 Bronchopulmonary Dysplasia Drug Market Size Projection by Geographic Region 2002, 2007
Table 10-3 Geographic Market Shares of Bronchopulmonary Dysplasia Drugs 2002
Table 10-4 Geographic Market Shares of Bronchopulmonary Dysplasia Drugs 2007
Table 11-1 Total World Respiratory Distress Syndrome Drug Market Size Projection 2002, 2007
Table 11-2 Respiratory Distress Syndrome Drug Market Size Projection by Geographic Region 2002, 2007
Table 11-3 Geographic Market Shares of Respiratory Distress Syndrome Drugs 2002
Table 11-4 Geographic Market Shares of Respiratory Distress Syndrome Drugs 2007
Table 12-1 Company Market Involvement by Pulmonary Disease Area

List of Figures

Figure 1-1 Total World Market Size Projection of Pulmonary/Lung Disease Therapeutics 2002, 2007
Figure 3-1 Total World COPD Drug Market Size Projection 2002, 200
Figure 3-2 COPD Drug Market Size Projection by Geographic Region 2002, 2007
Figure 3-3 Geographic Market Shares of COPD Drugs 2002
Figure 3-4 Geographic Market Shares of COPD Drugs 2007
Figure 3-5 COPD Drug Market Size Projection in U.S. 2002, 2007
Figure 3-6 COPD Drug Market Size Projection in Western Europe 2002, 2007
Figure 3-7 COPD Drug Market Size Projection in Japan 2002, 2007
Figure 3-8 COPD Drug Market Size Projection in Rest of World 2002, 2007
Figure 4-1 Total World Asthma Drug Market Size Projection 2002, 2007
Figure 4-2 Asthma Drug Market Size Projection by Geographic Region 2002, 2007
Figure 4-3 Geographic Market Shares of Asthma Drugs 2002
Figure 4-4 Geographic Market Shares of Asthma Drugs 2007
Figure 4-5 World Asthma Drug Market Share by Drug Class 2002
Figure 4-6 Asthma Drug Market Size Projection in U.S. 2002, 2007
Figure 4-7 Asthma Drug Market Size Projection in Western Europe 2002, 2007
Figure 4-8 Asthma Drug Market Size Projection in Japan 2002, 2007
Figure 4-9 Asthma Drug Market Size Projection in Rest of World 2002, 2007
Figure 5-1 Total World Cystic Fibrosis Drug Market Size Projection 2002, 2007
Figure 5-2 Cystic Fibrosis Drug Market Size Projection by Geographic Region 2002, 2007
Figure 5-3 Geographic Market Shares of Cystic Fibrosis Drugs 2002
Figure 5-4 Geographic Market Shares of Cystic Fibrosis Drugs 2007
Figure 5-5 Cystic Fibrosis Drug Market Size Projection in U.S. 2002, 2007
Figure 5-6 Cystic Fibrosis Drug Market Size Projection in Western Europe 2002, 2007
Figure 5-7 Cystic Fibrosis Drug Market Size Projection in Japan 2002, 2007
Figure 5-8 Cystic Fibrosis Drug Market Size Projection in Rest of World 2002, 2007
Figure 6-1 Total World Pulmonary Fibrosis Drug Market Size Projection 2002, 2007
Figure 6-2 Pulmonary Fibrosis Drug Market Size Projection by Geographic Region 2002, 2007
Figure 6-3 Geographic Market Shares of Pulmonary Fibrosis Drugs 2002
Figure 6-4 Geographic Market Shares of Pulmonary Fibrosis Drugs 2007
Figure 6-5 Pulmonary Fibrosis Drug Market Size Projection in U.S. 2002, 2007
Figure 6-6 Pulmonary Fibrosis Drug Market Size Projection in Western Europe 2002, 2007
Figure 6-7 Pulmonary Fibrosis Drug Market Size Projection in Japan 2002, 2007
Figure 6-8 Pulmonary Fibrosis Drug Market Size Projection in Rest of World 2002, 2007
Figure 7-1 Total World Pulmonary Hypertension Drug Market Size Projection 2002, 2007
Figure 7-2 Pulmonary Hypertension Drug Market Size Projection by Geographic Region 2002, 2007
Figure 7-3 Geographic Market Shares of Pulmonary Hypertension Drugs 2002
Figure 7-4 Geographic Market Shares of Pulmonary Hypertension Drugs 2007
Figure 7-5 Pulmonary Hypertension Drug Market Size Projection in U.S. 2002, 2007
Figure 7-6 Pulmonary Hypertension Drug Market Size Projection in Western Europe 2002, 2007
Figure 7-7 Pulmonary Hypertension Drug Market Size Projection in Japan 2002, 2007
Figure 7-8 Pulmonary Hypertension Drug Market Size Projection in Rest of World 2002, 2007
Figure 8-1 Total World Pulmonary Embolism Drug Market Size Projection 2002, 2007
Figure 8-2 Pulmonary Embolism Drug Market Size Projection by Geographic Region 2002, 2007
Figure 8-3 Geographic Market Shares of Pulmonary Embolism Drugs 2002
Figure 8-4 Geographic Market Shares of Pulmonary Embolism Drugs 2007
Figure 8-5 Pulmonary Embolism Drug Market Size Projection in U.S. 2002, 2007
Figure 8-6 Pulmonary Embolism Drug Market Size Projection in Western Europe 2002, 2007
Figure 8-7 Pulmonary Embolism Drug Market Size Projection in Japan 2002, 2007
Figure 8-8 Pulmonary Embolism Drug Market Size Projection in Rest of World 2002, 2007
Figure 9-1 Total World Pulmonary Sarcoidosis Drug Market Size Projection 2002, 2007
Figure 9-2 Pulmonary Sarcoidosis Drug Market Size Projection by Geographic Region 2002, 2007
Figure 9-3 Geographic Market Shares of Pulmonary Sarcoidosis Drugs 2002
Figure 9-4 Geographic Market Shares of Pulmonary Sarcoidosis Drugs 2007
Figure 9-5 Pulmonary Sarcoidosis Drug Market Size Projection in U.S. 2002, 2007
Figure 9-6 Pulmonary Sarcoidosis Drug Market Size Projection in Western Europe 2002, 2007
Figure 9-7 Pulmonary Sarcoidosis Drug Market Size Projection in Japan 2002, 2007
Figure 9-8 Pulmonary Sarcoidosis Drug Market Size Projection in Rest of World 2002, 2007
Figure 10-1 Total World Bronchopulmonary Dysplasia Drug Market Size Projection 2002, 2007
Figure 10-2 Bronchopulmonary Dysplasia Drug Market Size Projection by Geographic Region 2002, 2007
Figure 10-3 Geographic Market Shares of Bronchopulmonary Dysplasia Drugs 2002
Figure 10-4 Geographic Market Shares of Bronchopulmonary Dysplasia Drugs 2007
Figure 10-5 Bronchopulmonary Dysplasia Drug Market Size Projection in U.S. 2002, 2007
Figure 10-6 Bronchopulmonary Dysplasia Drug Market Size Projection in Western Europe 2002, 2007
Figure 10-7 Bronchopulmonary Dysplasia Drug Market Size Projection in Japan 2002, 2007
Figure 10-8 Bronchopulmonary Dysplasia Drug Market Size Projection in Rest of World 2002, 2007
Figure 11-1 Total World Respiratory Distress Syndrome Drug Market Size Projection 2002, 2007
Figure 11-2 Respiratory Distress Syndrome Drug Market Size Projection by Geographic Region 2002, 2007
Figure 11-3 Geographic Market Shares of Respiratory Distress Syndrome Drugs 2002
Figure 11-4 Geographic Market Shares of Respiratory Distress Syndrome Drugs 2007
Figure 11-5 Respiratory Distress Syndrome Drug Market Size Projection in U.S. 2002, 2007
Figure 11-6 Respiratory Distress Syndrome Drug Market Size Projection in Western Europe 2002, 2007
Figure 11-7 Respiratory Distress Syndrome Drug Market Size Projection in Japan 2002, 2007
Figure 11-8 Respiratory Distress Syndrome Drug Market Size Projection in Rest of World 2002, 2007

More Global Respiratory/Pulmonary Reports

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 by GlobalData
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 provides data ...

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 by GlobalData
Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 provides data on the ...

Lung Injury Global Clinical Trials Review, H1, 2012 by GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...

Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 provides data on the Bronchopulmonary Dysplasia ...

Bronchospasm Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchospasm Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2012 provides data on the Bronchospasm clinical trial scenario. ...

See all reports like this >>

Pulmonary/Lung Disease Therapeutics: Worldwide Markets and Developments

Share this report

Other tasks

Research Assistance

Related Markets

Respiratory/Pulmonary Reports

Free Alert Me service